PRODUCTS
Arena Life Science
Generic name: Ranolazine
Pharmacologic Category: Anti-anginal
Dosage Forms: 500 mg extended-release tablet
Mechanism of Action: A direct, selective inhibitor of Factor Xa
Ranolazine acts by inhibiting the cardiac late sodium current (INa) and hence prevents sodium dependent calcium accumulation in the cell.
It is important to know, 25-30% of patients with coronary artery disease have persistent angina pectoris despite of PCI with or without optimal medical therapy
No 20, 5th Floor , 8th Sharestan , Makoueipour St, Za'feraniyeh, Tehran-Iran
Phone: (+98) 21 26 80 5483 - 21 26 80 5489 - Fax: (+98)21 26 80 5478 Email: info@arenalifescience.com
All rights of this website belong to Arena Life Science